Asset Management
Compare Stocks
4 / 10Stock Comparison
CNS vs GROW vs DHIL vs VCTR
Revenue, margins, valuation, and 5-year total return — side by side.
Asset Management - Global
Asset Management
Asset Management
CNS vs GROW vs DHIL vs VCTR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Asset Management | Asset Management - Global | Asset Management | Asset Management |
| Market Cap | $3.63B | $35M | $473M | $5.36B |
| Revenue (TTM) | $517M | $8M | $158M | $1.31B |
| Net Income (TTM) | $164M | $98K | $49M | $452M |
| Gross Margin | 46.8% | 41.7% | 96.0% | 71.1% |
| Operating Margin | 33.4% | -35.3% | 38.4% | 42.5% |
| Forward P/E | 20.8x | — | 9.5x | 12.2x |
| Total Debt | $141M | $83K | $6.40B | $970M |
| Cash & Equiv. | $183M | $25M | $42M | $164M |
CNS vs GROW vs DHIL vs VCTR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Cohen & Steers, Inc. (CNS) | 100 | 111.9 | +11.9% |
| U.S. Global Investo… (GROW) | 100 | 125.4 | +25.4% |
| Diamond Hill Invest… (DHIL) | 100 | 164.0 | +64.0% |
| Victory Capital Hol… (VCTR) | 100 | 500.8 | +400.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CNS vs GROW vs DHIL vs VCTR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CNS is the #2 pick in this set and the best alternative if bank quality is your priority.
- NIM 2.4% vs DHIL's 0.7%
- Efficiency ratio 0.1% vs GROW's 0.8% (lower = leaner)
- Efficiency ratio 0.1% vs GROW's 0.8%
GROW lags the leaders in this set but could rank higher in a more targeted comparison.
DHIL carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- Dividend streak 1 yrs, beta 0.57, yield 5.7%
- Lower volatility, beta 0.57, current ratio 75115.85x
- PEG 1.14 vs CNS's 16.52
- Beta 0.57, yield 5.7%, current ratio 75115.85x
VCTR is the clearest fit if your priority is growth exposure and long-term compounding.
- Rev growth 46.2%, EPS growth -6.8%
- 6.8% 10Y total return vs CNS's 154.3%
- 46.2% NII/revenue growth vs GROW's -23.1%
- +46.1% vs CNS's -5.2%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 46.2% NII/revenue growth vs GROW's -23.1% | |
| Value | Lower P/E (9.5x vs 20.8x), PEG 1.14 vs 16.52 | |
| Quality / Margins | Efficiency ratio 0.1% vs GROW's 0.8% (lower = leaner) | |
| Stability / Safety | Beta 0.57 vs VCTR's 1.32 | |
| Dividends | 5.7% yield, 1-year raise streak, vs VCTR's 2.3% | |
| Momentum (1Y) | +46.1% vs CNS's -5.2% | |
| Efficiency (ROA) | Efficiency ratio 0.1% vs GROW's 0.8% |
CNS vs GROW vs DHIL vs VCTR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CNS vs GROW vs DHIL vs VCTR — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
VCTR leads in 2 of 6 categories
DHIL leads 2 • CNS leads 1 • GROW leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
VCTR leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
VCTR is the larger business by revenue, generating $1.3B annually — 154.5x GROW's $8M. DHIL is the more profitable business, keeping 30.9% of every revenue dollar as net income compared to GROW's -4.0%.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $517M | $8M | $158M | $1.3B |
| EBITDAEarnings before interest/tax | $198M | -$2M | $62M | $707M |
| Net IncomeAfter-tax profit | $164M | $98,000 | $49M | $452M |
| Free Cash FlowCash after capex | -$94M | -$235,000 | $44.5B | $422M |
| Gross MarginGross profit ÷ Revenue | +46.8% | +41.7% | +96.0% | +71.1% |
| Operating MarginEBIT ÷ Revenue | +33.4% | -35.3% | +38.4% | +42.5% |
| Net MarginNet income ÷ Revenue | +29.2% | -4.0% | +30.9% | +25.3% |
| FCF MarginFCF ÷ Revenue | +16.4% | -9.8% | -57.4% | +18.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +5.2% | — | +25.3% | +38.5% |
Valuation Metrics
DHIL leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 9.8x trailing earnings, DHIL trades at a 59% valuation discount to CNS's 23.9x P/E. Adjusting for growth (PEG ratio), DHIL offers better value at 1.18x vs CNS's 19.03x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $3.6B | $35M | $473M | $5.4B |
| Enterprise ValueMkt cap + debt − cash | $3.6B | $10M | $6.8B | $6.2B |
| Trailing P/EPrice ÷ TTM EPS | 23.94x | -104.80x | 9.77x | 20.51x |
| Forward P/EPrice ÷ next-FY EPS est. | 20.79x | — | 9.48x | 12.24x |
| PEG RatioP/E ÷ EPS growth rate | 19.03x | — | 1.18x | 2.84x |
| EV / EBITDAEnterprise value multiple | 19.48x | — | 110.39x | 9.82x |
| Price / SalesMarket cap ÷ Revenue | 7.01x | 4.14x | 3.00x | 4.10x |
| Price / BookPrice ÷ Book value/share | 6.30x | 0.77x | 2.70x | 2.29x |
| Price / FCFMarket cap ÷ FCF | 42.64x | — | — | 22.63x |
Profitability & Efficiency
CNS leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
CNS delivers a 28.3% return on equity — every $100 of shareholder capital generates $28 in annual profit, vs $0 for GROW. GROW carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to DHIL's 36.26x. On the Piotroski fundamental quality scale (0–9), DHIL scores 6/9 vs GROW's 2/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +28.3% | +0.2% | +27.0% | +18.7% |
| ROA (TTM)Return on assets | +20.5% | +0.2% | +19.5% | +10.7% |
| ROICReturn on invested capital | +19.2% | -4.7% | +1.3% | +15.2% |
| ROCEReturn on capital employed | +22.8% | -6.2% | +26.0% | +17.8% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 2 | 6 | 4 |
| Debt / EquityFinancial leverage | 0.25x | 0.00x | 36.26x | 0.40x |
| Net DebtTotal debt minus cash | -$42M | -$24M | $6.4B | $806M |
| Cash & Equiv.Liquid assets | $183M | $25M | $42M | $164M |
| Total DebtShort + long-term debt | $141M | $83,000 | $6.4B | $970M |
| Interest CoverageEBIT ÷ Interest expense | — | 600.00x | — | 10.35x |
Total Returns (Dividends Reinvested)
VCTR leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in VCTR five years ago would be worth $30,385 today (with dividends reinvested), compared to $4,143 for GROW. Over the past 12 months, VCTR leads with a +46.1% total return vs CNS's -5.2%. The 3-year compound annual growth rate (CAGR) favors VCTR at 43.0% vs GROW's 1.1% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +12.9% | +7.7% | +2.8% | +31.3% |
| 1-Year ReturnPast 12 months | -5.2% | +27.8% | +33.8% | +46.1% |
| 3-Year ReturnCumulative with dividends | +44.3% | +3.3% | +22.4% | +192.1% |
| 5-Year ReturnCumulative with dividends | +18.2% | -58.6% | +28.3% | +203.8% |
| 10-Year ReturnCumulative with dividends | +154.3% | +67.4% | +55.4% | +682.9% |
| CAGR (3Y)Annualised 3-year return | +13.0% | +1.1% | +7.0% | +43.0% |
Risk & Volatility
DHIL leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
DHIL is the less volatile stock with a 0.57 beta — it tends to amplify market swings less than VCTR's 1.32 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. DHIL currently trades 100.0% from its 52-week high vs GROW's 71.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.98x | 0.71x | 0.57x | 1.32x |
| 52-Week HighHighest price in past year | $83.99 | $3.65 | $175.03 | $88.42 |
| 52-Week LowLowest price in past year | $58.39 | $2.10 | $114.11 | $57.03 |
| % of 52W HighCurrent price vs 52-week peak | +84.7% | +71.8% | +100.0% | +94.7% |
| RSI (14)Momentum oscillator 0–100 | 63.1 | 46.5 | 70.5 | 75.9 |
| Avg Volume (50D)Average daily shares traded | 323K | 25K | 23K | 695K |
Analyst Outlook
Evenly matched — DHIL and VCTR each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CNS as "Sell", VCTR as "Buy". Consensus price targets imply 6.9% upside for CNS (target: $76) vs -6.8% for VCTR (target: $78). For income investors, DHIL offers the higher dividend yield at 5.71% vs VCTR's 2.26%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Sell | — | — | Buy |
| Price TargetConsensus 12-month target | $76.00 | — | — | $78.00 |
| # AnalystsCovering analysts | 13 | — | — | 13 |
| Dividend YieldAnnual dividend ÷ price | +3.3% | +3.5% | +5.7% | +2.3% |
| Dividend StreakConsecutive years of raises | 2 | 1 | 1 | 7 |
| Dividend / ShareAnnual DPS | $2.34 | $0.09 | $9.98 | $1.89 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.6% | +5.6% | +3.6% | +2.7% |
VCTR leads in 2 of 6 categories (Income & Cash Flow, Total Returns). DHIL leads in 2 (Valuation Metrics, Risk & Volatility). 1 tied.
CNS vs GROW vs DHIL vs VCTR: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CNS or GROW or DHIL or VCTR a better buy right now?
For growth investors, Victory Capital Holdings, Inc.
(VCTR) is the stronger pick with 46. 2% revenue growth year-over-year, versus -23. 1% for U. S. Global Investors, Inc. (GROW). Diamond Hill Investment Group, Inc. (DHIL) offers the better valuation at 9. 8x trailing P/E (9. 5x forward), making it the more compelling value choice. Analysts rate Victory Capital Holdings, Inc. (VCTR) a "Buy" — based on 13 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CNS or GROW or DHIL or VCTR?
On trailing P/E, Diamond Hill Investment Group, Inc.
(DHIL) is the cheapest at 9. 8x versus Cohen & Steers, Inc. at 23. 9x. On forward P/E, Diamond Hill Investment Group, Inc. is actually cheaper at 9. 5x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Diamond Hill Investment Group, Inc. wins at 1. 14x versus Cohen & Steers, Inc. 's 16. 52x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — CNS or GROW or DHIL or VCTR?
Over the past 5 years, Victory Capital Holdings, Inc.
(VCTR) delivered a total return of +203. 8%, compared to -58. 6% for U. S. Global Investors, Inc. (GROW). Over 10 years, the gap is even starker: VCTR returned +682. 9% versus DHIL's +55. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CNS or GROW or DHIL or VCTR?
By beta (market sensitivity over 5 years), Diamond Hill Investment Group, Inc.
(DHIL) is the lower-risk stock at 0. 57β versus Victory Capital Holdings, Inc. 's 1. 32β — meaning VCTR is approximately 130% more volatile than DHIL relative to the S&P 500. On balance sheet safety, U. S. Global Investors, Inc. (GROW) carries a lower debt/equity ratio of 0% versus 36% for Diamond Hill Investment Group, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CNS or GROW or DHIL or VCTR?
By revenue growth (latest reported year), Victory Capital Holdings, Inc.
(VCTR) is pulling ahead at 46. 2% versus -23. 1% for U. S. Global Investors, Inc. (GROW). On earnings-per-share growth, the picture is similar: Diamond Hill Investment Group, Inc. grew EPS 14. 4% year-over-year, compared to -126. 6% for U. S. Global Investors, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CNS or GROW or DHIL or VCTR?
Diamond Hill Investment Group, Inc.
(DHIL) is the more profitable company, earning 30. 9% net margin versus -4. 0% for U. S. Global Investors, Inc. — meaning it keeps 30. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: VCTR leads at 42. 5% versus -35. 3% for GROW. At the gross margin level — before operating expenses — DHIL leads at 96. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CNS or GROW or DHIL or VCTR more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Diamond Hill Investment Group, Inc. (DHIL) is the more undervalued stock at a PEG of 1. 14x versus Cohen & Steers, Inc. 's 16. 52x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Diamond Hill Investment Group, Inc. (DHIL) trades at 9. 5x forward P/E versus 20. 8x for Cohen & Steers, Inc. — 11. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CNS: 6. 9% to $76. 00.
08Which pays a better dividend — CNS or GROW or DHIL or VCTR?
All stocks in this comparison pay dividends.
Diamond Hill Investment Group, Inc. (DHIL) offers the highest yield at 5. 7%, versus 2. 3% for Victory Capital Holdings, Inc. (VCTR).
09Is CNS or GROW or DHIL or VCTR better for a retirement portfolio?
For long-horizon retirement investors, Diamond Hill Investment Group, Inc.
(DHIL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 57), 5. 7% yield). Both have compounded well over 10 years (DHIL: +55. 4%, CNS: +154. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CNS and GROW and DHIL and VCTR?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: CNS is a small-cap income-oriented stock; GROW is a small-cap income-oriented stock; DHIL is a small-cap deep-value stock; VCTR is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.